Skip to main content
Premium Trial:

Request an Annual Quote

Metrion Biosciences: David Milroy, Steve Carle

Metrion Biosciences has made a series of changes to its board of directors. David Milroy has joined the firm's board as the investor director for Maven Capital Partners and Steve Carle has replaced Maya Ward as the board representative for Gresham House Ventures. Marc Rogers, Barry Kenny and Mark Keogh have retired as non-executive directors.